NCT00348452View on ClinicalTrials.gov

A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

August 31, 2003

Conditions

Chronic Pain

Interventions

DRUG

tramadol HCl ER; celecoxib

All Listed Sponsors

lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00348452 - A Study Comparing the Effectiveness and Safety of Extended Release Tramadol HCl at 100 mg, 200 mg and 300 mg Doses to Placebo for the Treatment of Moderate to Severe Pain Due to Osteoarthritis (OA) | Biotech Hunter | Biotech Hunter